Siglec‐G Suppresses CD8+ T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy.
Saved in:
| Title: | Siglec‐G Suppresses CD8+ T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy. |
|---|---|
| Authors: | Yin, Shenhui1 (AUTHOR), Li, Chunzhen1 (AUTHOR), Shen, Xin1 (AUTHOR), Yu, Guanyu2 (AUTHOR), Cui, Likun1 (AUTHOR), Wu, Yunyang1 (AUTHOR), He, Yixian1 (AUTHOR), Yu, Shu1 (AUTHOR), Chen, Jie1 (AUTHOR), Lu, Shaoteng1 (AUTHOR), Qiu, Guifang1 (AUTHOR), Song, Mengqi1 (AUTHOR), Qian, Cheng1 (AUTHOR), Zou, Zui3,4 (AUTHOR) zouzui@smmu.edu.cn, Yu, Yizhi1 (AUTHOR) yuyz@immunol.org, Xu, Sheng1 (AUTHOR) xusheng@immunol.org |
| Source: | Advanced Science. 12/4/2024, Vol. 11 Issue 45, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21983844 |
|---|---|
| DOI: | 10.1002/advs.202403438 |